Amgen Inc.
CHIMERIC RECEPTORS AND METHODS OF USE THEREOF

Last updated:

Abstract:

Antigen binding molecules, chimeric receptors, and engineered immune cells are disclosed in accordance with the invention. The invention further relates to vectors, compositions, and methods of treatment and/or detection using the antigen binding molecules and engineered immune cells.

Status:
Application
Type:

Utility

Filling date:

21 Oct 2019

Issue date:

16 Apr 2020